The Beauty Health Company $SKIN Shares Sold by 180 Wealth Advisors LLC

180 Wealth Advisors LLC decreased its position in The Beauty Health Company (NASDAQ:SKIN) by 21.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 63,990 shares of the company’s stock after selling 17,832 shares during the quarter. 180 Wealth Advisors LLC owned 0.05% of Beauty Health worth $122,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. Newman Dignan & Sheerar Inc. grew its position in shares of Beauty Health by 28.1% in the 2nd quarter. Newman Dignan & Sheerar Inc. now owns 91,144 shares of the company’s stock worth $174,000 after acquiring an additional 20,000 shares in the last quarter. Simplicity Wealth LLC acquired a new position in shares of Beauty Health in the 2nd quarter worth approximately $49,000. AQR Capital Management LLC acquired a new position in shares of Beauty Health in the 1st quarter worth approximately $40,000. Kapitalo Investimentos Ltda acquired a new position in shares of Beauty Health in the 2nd quarter worth approximately $60,000. Finally, Goldman Sachs Group Inc. grew its position in shares of Beauty Health by 5.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 665,706 shares of the company’s stock worth $892,000 after acquiring an additional 31,880 shares in the last quarter. Institutional investors and hedge funds own 93.26% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Zacks Research upgraded Beauty Health from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 21st. TD Cowen boosted their price objective on Beauty Health from $2.00 to $2.50 and gave the company a “hold” rating in a research report on Monday, September 22nd. Stifel Nicolaus boosted their price objective on Beauty Health from $3.00 to $4.00 and gave the company a “hold” rating in a research report on Friday, August 1st. Cowen restated a “hold” rating on shares of Beauty Health in a research report on Monday, September 22nd. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Beauty Health in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $2.81.

Beauty Health Trading Up 6.9%

NASDAQ:SKIN opened at $1.39 on Monday. The Beauty Health Company has a 1 year low of $0.78 and a 1 year high of $2.69. The stock has a market cap of $176.28 million, a price-to-earnings ratio of -4.96 and a beta of 1.21. The business has a fifty day moving average of $1.94 and a 200-day moving average of $1.72. The company has a debt-to-equity ratio of 4.91, a quick ratio of 4.15 and a current ratio of 5.15.

Beauty Health (NASDAQ:SKIN) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.09. Beauty Health had a negative return on equity of 32.82% and a negative net margin of 6.13%.The company had revenue of $78.20 million during the quarter, compared to analysts’ expectations of $74.67 million. Beauty Health has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities analysts predict that The Beauty Health Company will post -0.25 earnings per share for the current year.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.